5-6-circle

2-circle
4-circle

Premier, Inc. continues growth trajectory with acquisition of Hospira’s TheraDoc

By | News | No Comments

Premier, Inc. (NASDAQ: PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117 million in cash, subject to potential purchase price adjustments regarding TheraDoc’s actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier’s fiscal 2015 first quarter ending September 30, 2014, subject to customary closing conditions.

TheraDoc is a wholly-owned subsidiary of Hospira (NYSE: HSP). Premier’s board of directors unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117 million represents a purchase price multiple in the 10-11 times range.

Read More

Article in Infection Control and Hospital Epidemiology concludes TheraDoc alerting combined with antimicrobial stewardship intervention has multiple postive effects

By | News | No Comments

The article illustrates how TheraDoc’s active alerting was used in combination with antimicrobial stewardship interventions on patients with gram-negative bacteremia. The study discussed in this article was a quasi-experimental retrospective cohort study conducted at three hospitals within Detroit Medical Center, with a combined 1,100 beds. Data resulting from active alerting of a positive blood culture coupled with stewardship intervention was compiled during 2010–2011 and compared to data from patients who received no formalized stewardship intervention during 2009.

Read More

Hospira’s TheraDoc™ Infection Control Assistant™ Ranked #1 in its Category by KLAS for Second Consecutive Year

By | News | No Comments

Hospira (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies, today announced that, for the second consecutive year, its TheraDoc™ Infection Control Assistant™ software has been ranked as the top product in the Infection Control & Monitoring software category in the recently released Best in KLAS Awards 2013: Software and Services Report (more information available at www.theradoc.com). The full report is available at www.KLASresearch.com. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions.

TheraDoc Infection Control Assistant scored the highest overall performance rating in KLAS’ Infection Control & Monitoring market segment, demonstrating continued excellence and leadership in serving customers and meeting their expectations.[1]

Read More